Edgar Lomax Company’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-54,914
Closed -$1.67M 66
2021
Q4
$1.67M Sell
54,914
-455
-0.8% -$14.8K 0.1% 56
2021
Q3
$1.82M Sell
55,369
-1,580
-3% -$50.6K 0.12% 56
2021
Q2
$1.72M Buy
+56,949
New +$1.87M 0.11% 56

Other funds holding OGN

Edgar Lomax Company's OGN Position: Q1 2022 in Review

Edgar Lomax Company sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 54,914 shares — an estimated $1.67M sold.

Edgar Lomax Company first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $1.82M in Q3 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Edgar Lomax Company reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Edgar Lomax Company sold 54,914 Organon & Co shares in Q1 2022, an estimated $1.67M.
  • Edgar Lomax Company first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Edgar Lomax Company's Organon & Co position peaked at $1.82M in Q3 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Edgar Lomax Company's 13F filing for Q1 2022, filed 13 May 2022.